Predictors of Long-term Opioid Use Following Lumbar Fusion Surgery

被引:110
|
作者
Connolly, Joseph, III [1 ,2 ]
Javed, Zulqarnain [2 ]
Raji, Mukaila A. [1 ,2 ,3 ,4 ]
Chan, Winston [2 ]
Kuo, Yong-Fang [1 ,2 ,3 ,4 ]
Baillargeon, Jacques [1 ,2 ,4 ]
机构
[1] US Air Force, Sch Aerosp Med, Wright Patterson AFB, OH 45433 USA
[2] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA
[4] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
comorbidity; depression; low back pain; lumbar fusion; minimally invasive fusion; opioids; smoking; DEGENERATIVE DISC DISEASE; QUALITY-OF-LIFE; INTERBODY FUSION; SPINAL STENOSIS; DATABASE ANALYSIS; OUTCOMES; ANTERIOR; PAIN; SMOKING; DEPRESSION;
D O I
10.1097/BRS.0000000000002133
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A population-based retrospective cohort study. Objective. The aim of this study was to examine risk factors for long-term opioid use following lumbar spinal fusion surgery in a nationally representative cohort of commercially insured adults. Summary of Background Data. Opioid prescription rates for the management of low back pain have more than doubled in the US over the past decade. Although opioids are commonly used for the management of pain following lumbar spinal fusion surgery, to date, no large-scale nationally representative studies have examined the risk factors for long-term opioid use following such surgical intervention. Methods. Using one of the nation's largest commercial insurance databases, we conducted a retrospective cohort study of 8377 adults, aged 21 to 63 years, who underwent lumbar spinal fusion surgery between January 1, 2009, and December 31, 2012. Long-term opioid use was defined as >= 365 days of filled opioid prescriptions in the 24 months following lumbar fusion. Multivariable logistic regression was used to calculate adjusted odds ratios (ORs) and 95% confidence intervals for the risk of long-term opioid use following lumbar fusion. Results. After adjusting for covariates, the following factors were associated with an increased risk of long-term opioid use following surgery: duration of opioid use in the year before lumbar surgery [Referent (0 days); Quartile 1 (1-22 days) OR = 2.27, 95% CI = 1.48-3.49; Quartile 2 (23-72 days): OR = 5.94, 95% CI = 4.00-8.83; Quartile 3: (73-250 days) OR = 25.31, 95% CI = 17.26-37.10; Quartile 4 (>= 250 days) OR = 219.95, 95% CI = 148.53-325.71)], refusion surgery (OR = 1.32, 95% CI = 1.02-1.72), and diagnosis of depression (OR = 1.43, 95% CI =1.18-1.74). Receipt of anterior fusion was associated with a modest decrease in the risk of long-term opioid use (OR = 0.79, 95% CI = 0.63-0.99). Conclusion. These findings may provide clinically relevant information to physicians, patients, and their families regarding the risk factors for opioid dependence following lumbar fusion surgery.
引用
收藏
页码:1405 / 1411
页数:7
相关论文
共 50 条
  • [1] Post-Operative Complications Associated with Long-Term NSAID or Long-Term Opioid Use Prior to Lumbar Spinal Fusion Surgery
    Ballatori, Alexander M.
    Shahrestani, Shane
    Ton, Andy
    Chen, Xiao
    Gettleman, Brandon S.
    Buser, Zorica
    Wang, Jeffrey C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 236
  • [2] Long-Term Opioid Use Following Surgery for Symptomatic Neuroma
    Lans, Jonathan
    Westenberg, Ritsaart F.
    Gottlieb, Rachel E.
    Valerio, Ian L.
    Chen, Neal C.
    Eberlin, Kyle R.
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2022, 38 (02) : 137 - 143
  • [3] Predictors of Long-Term Opioid Use Among Patients With Painful Lumbar Spine Conditions
    Krebs, Erin E.
    Lurie, Jon D.
    Fanciullo, Gilbert
    Tosteson, Tor D.
    Blood, Emily A.
    Carey, Timothy S.
    Weinstein, James N.
    JOURNAL OF PAIN, 2010, 11 (01): : 44 - 52
  • [4] Predictors of long-term opioid dependence in transforaminal lumbar interbody fusion with a focus on pre-operative opioid usage
    Hockley, Aaron
    Ge, David
    Vasquez-Montes, Dennis
    Moawad, Mohamed A.
    Passias, Peter Gust
    Errico, Thomas J.
    Buckland, Aaron J.
    Protopsaltis, Themistocles S.
    Fischer, Charla R.
    EUROPEAN SPINE JOURNAL, 2020, 29 (06) : 1311 - 1317
  • [5] Predictors of long-term opioid dependence in transforaminal lumbar interbody fusion with a focus on pre-operative opioid usage
    Aaron Hockley
    David Ge
    Dennis Vasquez-Montes
    Mohamed A. Moawad
    Peter Gust Passias
    Thomas J. Errico
    Aaron J. Buckland
    Themistocles S. Protopsaltis
    Charla R. Fischer
    European Spine Journal, 2020, 29 : 1311 - 1317
  • [6] Prevalence and predictors of long-term opioid use following orthopaedic surgery in an Australian setting: A multicentre, prospective cohort study
    Liu, Shania
    Stevens, Jennifer A.
    Collins, Ashleigh E.
    Duff, Jed
    Sutherland, Joanna R.
    Oddie, Morgan D.
    Naylor, Justine M.
    Patanwala, Asad E.
    Suckling, Benita M.
    Penm, Jonathan
    ANAESTHESIA AND INTENSIVE CARE, 2023, 51 (05) : 321 - 330
  • [7] Opioid use following cervical spine surgery: trends and factors associated with long-term use
    Pugely, Andrew J.
    Bedard, Nicholas A.
    Kalakoti, Piyush
    Hendrickson, Nathan R.
    Shillingford, Jamal N.
    Laratta, Joseph L.
    Saifi, Comron
    Lehman, Ronald A.
    Riew, K. Daniel
    SPINE JOURNAL, 2018, 18 (11): : 1974 - 1981
  • [8] Perioperative predictors of long-term pain following surgery
    Katz, J
    PROCEEDINGS OF THE 8TH WORLD CONGRESS ON PAIN, 1997, 8 : 231 - 240
  • [9] Long-term opioid use after bariatric surgery
    Maciejewski, Matthew L.
    Smith, Valerie A.
    Berkowitz, Theodore S. Z.
    Arterburn, David E.
    Bradley, Katharine A.
    Olsen, Maren K.
    Liu, Chuan-Fen
    Livingston, Edward H.
    Funk, Luke M.
    Mitchell, James E.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (08) : 1100 - 1110
  • [10] Patterns and predictors of long-term opioid use in older adults
    Oh, Gyeon
    Abner, Erin L.
    Fardo, David W.
    Freeman, Patricia R.
    Moga, Daniela C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 327 - 327